Effective treatment modality for infectious diseases, pulmonary conditons and sequelae thereof
US5658937A · kind A · utility
1Cited by
12References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 30, 1994 |
| Grant date | Aug 19, 1997 |
| Priority date | — |
| Expiry date | Sep 30, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A treatment modality for infectious diseases and pulmonary conditions that result from the inflammatory responses by tissues to infections by microorganisms, including but not limited to viruses, retroviruses, bacteria, or other microorganisms, or toxins that arise from microorganisms comprises administering an effective amount of histidine to the affected subject to combat the disease or the distress condition resulting therefrom.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.